olmesartan has been researched along with atenolol in 5 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (atenolol) | Trials (atenolol) | Recent Studies (post-2010) (atenolol) |
---|---|---|---|---|---|
841 | 185 | 554 | 5,473 | 1,950 | 852 |
Protein | Taxonomy | olmesartan (IC50) | atenolol (IC50) |
---|---|---|---|
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.7468 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.23 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.23 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.23 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Averill, DB; Brosnihan, KB; Ferrario, CM; Schiffrin, EL; Smith, RD; Yokoyama, H | 1 |
Agabiti-Rosei, E; Laeis, P; Ludwig, M; Scholze, J; Schremmer, D; Schwandt, P; Stumpe, KO; Zielinski, T | 1 |
Brown, I; Gallivan, C | 1 |
1 trial(s) available for olmesartan and atenolol
Article | Year |
---|---|
Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Atenolol; Carotid Arteries; Carotid Artery Diseases; Female; Humans; Hypertension; Imidazoles; Male; Middle Aged; Pilot Projects; Tetrazoles; Treatment Outcome; Tunica Intima; Tunica Media; Ultrasonography | 2007 |
4 other study(ies) available for olmesartan and atenolol
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiomegaly; Collagen; Disease Progression; Endothelium, Vascular; Heart Rate; Hypertension; Imidazoles; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Vascular Diseases; Vascular Resistance | 2005 |
[Lowering blood pressure and more? AT1 antagonist reduced plaque volume].
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Atenolol; Blood Pressure; Carotid Stenosis; Humans; Hypertension; Imidazoles; Randomized Controlled Trials as Topic; Tetrazoles | 2008 |
Olmesartan induced enterocolitis.
Topics: Aged; Amitriptyline; Anticholesteremic Agents; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Atenolol; Atorvastatin; Dihydropyridines; Enterocolitis; Female; Heptanoic Acids; Humans; Imidazoles; Pyrroles; Tetrazoles | 2014 |